Bausch & Lomb PureVision 30-Day Indication Receives FDA Go-Ahead
This article was originally published in The Gray Sheet
Executive Summary
A hearing to address patent infringement allegations by Bausch & Lomb over Ciba Vision's extended-wear contact lenses will take place in January in Rochester, New York federal court, according to B&L